India's Zim Laboratories hits near 2-month high on new U.S. patent issue

Zim Laboratories

09/06/2020 08:02

** Shares of Indian manufacturer of drug delivery solutions
 ZIML.BO  rise as much as 20% to hit an upper circuit at 81
rupees - their highest since April 16
    ** ZIML on Monday said it had been issued a new U.S. patent
for its invention of "Pharmaceutical Microemulsions Immobilized
In A Thin Polymer Matrix And Methods Of Making Same"
 urn:newsml:reuters.com:*:nFWN2DK027
    ** Microemulsions are a medium for drug delivery that can be
used to enhance penetration of active pharmaceutical ingredients
from the point of administration  
    ** Thin polymer matrix or thin films are a non-invasive form
of dosing drugs and can be given by various routes of
administration including topical, oral, and nasal
    ** ZIML's invention combines these two forms of drug
delivery, and will enable co to deliver many large molecules
that currently can be dosed only through injections  
    ** Up to Monday's close, stock had fallen 4.3% YTD

 (Reporting by Anuron Kumar Mitra in Bengaluru)
 ((AnuronKumar.Mitra@thomsonreuters.com; +91 99863 58469;))